Summary
Renal microsomes isolated on day 3 from cis-platin (CDDP, single i.p. injection, 4 or 6 mg/kg)-treated rats were monitored for their susceptibility to lipid peroxidation as compared with microsomes from rats treated with carboplatin (CBDCA, 30 mg/kg), transplatin (TDDP, 6 mg/kg) or CDDP hydrolysis products (4 or 6 mg/kg) or from control animals. Cephaloridine (1 g/kg daily for 4 days, i.p. injection) was used as a positive control. The effect of CDDP on renal microsomal glucose-6-phosphatase activity was investigated in vivo and in vitro. Following treatment with CDDP and CDDP hydrolysis products vs CBDCA and TDDP treatment, microsomes revealed an enhanced susceptibility to lipid peroxidation in a Fe2+ and/or ascorbic acid stimulation system. Increased lipid peroxidation, expressed as an increase in malondialdehyde (MDA) generation, paralleled the alterations in body and kidney weight and the elevations of plasma creatinine and blood urea nitrogen concentrations. Injection of the antioxidantN,N′-diphenyl-p-phenylenediamine (DPPD, 0.5 g/kg, i.p.) at 24 h prior to CDDP treatment abolished the increased vulnerability of renal microsomes to lipid peroxidation. In vivo, only CDDP hydrolysis products exhibited a significant inhibitory effect on renal glucose-6-phosphatase activity. In vitro, rat renal and hepatic microsomal glucose-6-phosphatase activity was decreased by CDDP both time-and concentration-dependently. Nephrotoxicity induced by CDDP and CDDP hydrolysis products might be attributable to iron-dependent lipid peroxidation and microsomes might represent target organelles on a subcellular level.
Similar content being viewed by others
References
Albro PW, Corbett JT, Schroeder JL (1987) Rapid isolation of microsomes for studies of lipid peroxidation. Lipids 22: 751
Baginski ES, Foa PP, Zak B (1974) Glucose-6-phosphatase. In: Bergmeyer HU (ed) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim, p 909
Beckmann JK, Borowitz SM, Greene HL, Burr IM (1988) Promotion of iron-induced rat liver microsomal lipid peroxidation by copper. Lipids 23: 559
Bompart G (1989) Cisplatin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex. Toxicol Lett 48: 193
Braughler JM, Duncan LA, Chase RL (1986) The involvement of iron in lipid peroxidation. J Biol Chem 261: 10282
Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302
Choie DD, Del Campo AA, Guarino AM (1980) Subcellular localization ofcis-dichlorodiammineplatinum(II) in rat kidney and liver. Toxicol Appl Pharmacol 55: 245
Cojocel C, Hannemann J, Baumann K (1985) Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochim Biophys Acta 834: 402
Daley-Yates PT, McBrien DCH (1984) Clsplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 33: 3063
Dobyan DC, Bull JM, Strebel FR, Sunderland BA, Bulger RE (1986) Protective effects ofO-(β-hydroxyethyl)-rutoside on cis-platinuminduced acute renal failure in the rat. Lab Invest 55: 557
Ernster L, Nordenbrand K (1967) Microsomal lipid peroxidation. Methods Enzymol 10: 574
Ernster L, Nordenbrand K, Orrenius S (1982) Microsomal lipid peroxidation: mechanism and some biomedical implications. In: Yagi K (ed) Lipid peroxides in biology and medicine. Academic Press, New York, p 55
Fujimoto Y, Fujita T (1982) Effect of lipid peroxidation onp-aminohippurate transport by rat kidney cortical slices. Br J Pharmacol 76: 373
Gatzemeier U, Heckmayr M, Hossfeld DK, Zschaber R, Achterrath W, Lenaz L (1990) Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer. Cancer Chemother Pharmacol 26: 369
Gemba M, Fukuishi N, Nakano S (1988) Effect ofN,N′-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats. Jpn J Pharmacol 46: 90
Goldstein RS, Mayor GH (1983) Minireview: the nephrotoxicity of cisplatin. Life Sci 32: 685
Goldstein RS, Pasino DA, Hewitt WR, Hook JB (1986) Biochemical mechanisms of cephaloridine nephrotoxicity: time and concentration dependence of peroxidative injury. Toxicol Appl Pharmacol 83: 261
Goldstein RS, Contardi LR, Pasino DA, Hook JB (1987) Mechanisms mediating cephaloridine-inhibition of renal gluconeogenesis. Toxicol Appl Pharmacol 87: 297
Hannemann J, Baumann K (1988) Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51: 119
Hannemann J, Baumann K (1988) Inhibition of lactate dehydrogenase by cisplatin and other platinum compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitro. Res Commun Chem Pathol Pharmacol 60: 371
Hannemann J, Baumann K (1990) Nephrotoxicity of cisplatin, carboplatin and transplantin: a comparative in vitro study. Arch Toxicol 64: 393
Hannemann J, Duwe J, Baumann K (1989–1990) Lipid peroxidation in renal microsomes of cisplatin (CP)-treated rats. Renal Failure II: 249
Hannemann J, Duwe J, Baumann K (1991) Lipid peroxidation in renal microsomes of cisplatin-treated rats. In: Bach PH, Gregg NJ, Wilks MF, Delacruz L (eds) Nephrotoxicity: mechanisms, early diagnosis and therapeutic management. Marcel Dekker, New York, p 305
Iba MM, Mannering GJ (1987) NADPH- and linoleic acid hydroperoxide-induced lipid peroxidation and destruction of cytochrome P-450 in hepatic microsomes. Biochem Pharmacol 36: 1447
Kletter G, Parks BR, Bhatnagar A, Iyer RV (1988) Elevated serum iron levels following administration of cisplatinum. Oncology 45: 421
Lelieveld P, Vijgh WJF van der, Veldhuizen RW, Velzen D van, Putten LM van, Atassi G, Danguy A (1984) Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives. Eur J Cancer Clin Oncol 20: 1087
Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A (1971) Antileukaemic and nephrotoxic properties of platinum compounds. Nature 234: 43
Litterst CL, Uozumi J (1986) Correlation between cisplatin toxicity and chemically-induced alterations in tissue glutathione levels. Proc Am Assoc Cancer Res 27: 287
Minotti G, Aust SD (1987) The role-of iron in the initiation of lipid peroxidation. Chem Phys Lipids 44: 191
Minotti G, Aust SD (1989) The role of iron in oxygen radical mediated lipid peroxidation. Chem Biol Interact 71: 1
Nakano S, Gemba M (1989) Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol 50: 89
Pederson TC, Aust SD (1972) NADPH-dependent lipid peroxidation catalyzed by purified NADPH-cytochrome C reductase from rat liver microsomes. Biochem Biophys Res Commun 48: 789
Reeves PG, Saari JT (1990) Effect ofcis-diamminedichloroplatinum(II) on metallothionein induction and trace element metabolism in rats fed different amounts of dietary zinc. J Nutr Biochem 1: 374
Safirstein R, Miller P, Guttenplan JB (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int 25: 753
Schacterle GR, Pollack RL (1973) A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 51: 654
Sedgwick B, Hübscher G (1965) Metabolism of phospholipids: IX. Phosphatidate phosphohydrolase in rat liver. Biochim Biophys Acta 106: 63
Shenberg C, Izak-Biran T, Mantel M, Rachmiel B, Weininger J, Chaitchik S (1989) Effect of selenite on the toxicity ofcis-DDP in mice: estimation of trace elements. J Trace Elem Electrolytes Health Dis 3: 71
Sugihara K, Gemba M (1986) Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 40: 353
Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M (1987) Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 43: 247
Sugihara K, Nakano S, Gemba M (1987) Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 44: 71
Vile GF, Winterbourn CC (1989) Microsomal lipid peroxidation induced by Adriamycin, epirubicin, daunorubicin and mitoxantrone: a comparative study. Cancer Chemother Pharmacol 24: 105
Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM (1979) Toxic effects ofcis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63: 1527
Younes M, Eberhardt I, Lemoine R (1989) Effect of iron overload on spontaneous and xenobiotic-induced lipid peroxidation in vivo. J Appl Toxicol 9: 103
Zhong LF, Zhang JG, Zhang M, Ma XL, Xia YX (1990) Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats. Arch Toxicol 64: 599
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hannemann, J., Duwe, J. & Baumann, K. Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds. Cancer Chemother. Pharmacol. 28, 427–433 (1991). https://doi.org/10.1007/BF00685818
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00685818